Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oxaliplatin + S-1 for advanced primary liver cancer
ChiCTR-OPC-15005892Phase 2Recruiting
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Start
- Jan 2015
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin and tegafur in hepatocellular carcinoma (HCC), sponsored by Cancer Hospital of Guangxi Medical University. Primary endpoint: Diameter of target lesion. Started Jan 2015; status: recruiting.
02
Drugs
oxaliplatintegafur
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-OPC-15005892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15005892.